Učitavanje...

Targeting TRPV3 for the Development of Novel Analgesics

Decades of characterization of the transient receptor potential vanilloid subtype 1 (TRPV1) has led to the realization of its central role in thermosensation and pain perception. A large number of pharmaceutical companies have had interest in developing TPRV1 antagonists for the treatment of pain. T...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Huang, Susan M., Chung, Man-Kyo
Format: Artigo
Jezik:Inglês
Izdano: 2013
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4182939/
https://ncbi.nlm.nih.gov/pubmed/25285178
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!